Healthcare

Sarah Dolan Joins Women’s Care Florida as New OB/GYN

TAMPA, FL / ACCESSWIRE / October 18, 2024 / Women's Care is excited to announce the addition of Dr. Sarah…

3 months ago

Deanna Caminiti, MD Joins Women’s Care in Lakewood Ranch, Florida

BRADENTON, FL / ACCESSWIRE / October 18, 2024 / Women's Care is excited to announce the addition of Dr. Deanna…

3 months ago

Jean Health Announces Expansion into Australia: Solving Urgent Rural Maternity Care Needs

Jean Health has announced its expansion into Australia to address the urgent maternity care needs in rural areas. The company…

3 months ago

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

The pace of patient enrollment has significantly accelerated following a summertime slowdown DENVER, Oct. 18, 2024 (GLOBE NEWSWIRE) -- SeaStar…

3 months ago

Alignment Healthcare to Announce Third Quarter 2024 Financial Results and Host Conference Call Tuesday, Oct. 29, 2024

ORANGE, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2024 financial…

3 months ago

UPDATE — Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition

Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets,…

3 months ago

KFSHRC Leads Healthcare Intelligence in Diagnostics and Patient Care

RIYADH, Saudi Arabia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is contributing to…

3 months ago

Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence,…

3 months ago

Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition

Combined company will emerge as a leading global health and wellness company by providing better products and solutions for pets,…

3 months ago

Novo Nordisk A/S: Alhemo® recommended for European approval as first once-daily subcutaneous prophylactic treatment for people living with haemophilia A or B with inhibitors

Bagsværd, Denmark, 18 October 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products…

3 months ago